GenSight Biologics Market Cap

GenSight Biologics has a market cap or net worth of $30.31 million as of May 15, 2025. Its market cap has decreased by -8.73% in one year.

Market Cap

30.31M

Enterprise Value

48.96M

Revenue

2.72M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.24

Market Cap Chart

Since July 13, 2016, GenSight Biologics's market cap has decreased from 279.96M to 30.31M, a decrease of -89.17%. That is a compound annual growth rate of -22.23%.

Market Cap History

Date	Market Cap	% Change
May 14, 2025	30.31M	-11.43%
Dec 31, 2024	34.22M	20.63%
Dec 29, 2023	28.37M	-82.90%
Dec 30, 2022	165.86M	-42.89%
Dec 31, 2021	290.43M	-21.99%
Dec 31, 2020	372.30M	308.86%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.64B
Nika Pharmaceuticals	1.02B
Veradigm	712.65M
Tian'an Technology Group	591.73M
CytoDyn	510.85M
Glass House Brands	506.85M
Elite Pharmaceuticals	471.06M
Northwest Biotherapeutics	411.95M

Market Cap Rankings